Taira N, Kashiwabara K, Tsurutani J, Kitada M, et al. Correction to: Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer. Breast Cancer 2021 Sep 25. pii: 10.1007/s12282-021-01296.
PMID: 34562260